Intimation about intention of promoters to participate in buyback
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty 100 and 2.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Zydus Lifesciences has announced that its promoter group and persons in control have communicated their intention to participate in the company's upcoming buyback programme. The buyback involves up to 95,65,217 equity shares (0.95% of total paid-up capital) at INR 1,150 per share, aggregating to INR 1,100 crore. The buyback is being conducted on a proportionate basis through the tender offer route under the Companies Act, 2013 and SEBI Buyback Regulations. Promoters have indicated they will tender shares up to their respective holding or lower as permitted by law.
Promoter participation signals confidence in the company's intrinsic value and may provide support to the stock. The INR 1,150 buyback price likely represents a premium to prevailing market rates, offering existing shareholders an opportunity to exit at a favourable price.